Clinical Trials on Ocular Inflammatory Disease

Total 383090 results

Alcon Research

Completed

Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy

Glaucoma

United States
Alcon Research

Completed

Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

Glaucoma

Argentina
Alcon Research

Completed

Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

Glaucoma

Germany
Wills Eye

Completed

Will Listening to Music Make it Easier to Take a Visual Field Test?

Glaucoma

United States
First Affiliated Hospital of Fujian Medical University

Unknown

Clinical Study of LPI With Different Laser Wavelengths

Glaucoma
First Affiliated Hospital of Fujian Medical University

Unknown

Clinical Study of LPI on Different Sites of Iris

Glaucoma
Johns Hopkins University

Completed

Does Oral Acetaminophen Lower Intraocular Pressure?

Glaucoma

United States
University of California, Los Angeles

Completed

Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma

Glaucoma

United States
Allergan

Terminated

A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

Glaucoma

United Kingdom, Taiwan, Korea, Republic of, United States, Italy, Philippines, France
Queen's University

Terminated

Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion

Glaucoma

Canada
Alcon Research

Completed

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America

Glaucoma
University of Turin, Italy
University of Siena

Unknown

MIGS VS SLT Comparison in Glaucoma Patients

Glaucoma

Italy
Maastricht University Medical Center
Aeon Astron Europe B.V.

Terminated

Trabeculectomy With Ologen

Glaucoma

Netherlands
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

Glaucoma

France
University of Toronto

Completed

Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy

Glaucoma

Canada
Sensimed AG

Completed

An Open Label Study Assessing the 24-hour Intraocular Pressure Pattern in PAC and PACG Patients, Before and After Laser Peripheral Iridotomy

Glaucoma

India
University of Milan

Completed

Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures

Glaucoma

Germany, Greece, Italy, Switzerland, United Kingdom
Tema Christian Eye Center
International Glaucoma Association; HCA International Foundation

Unknown

The Ghana Primary Tube Versus Trabeculectomy Study (GPTVT)

Glaucoma

Ghana
Prince of Songkla University

Completed

Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome (Bevacizumab)

Glaucoma

Thailand
Duke University
University of Alabama at Birmingham

Completed

Partnership for Glaucoma

Glaucoma

United States
Alcon Research

Terminated

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil

Glaucoma

Brazil
Alcon Research

Completed

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

Glaucoma

United States
Semmelweis University

Completed

Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect

Ocular Hypertension | Glaucoma

Hungary
Yale University
Pfizer

Completed

Effect of Age on Latanoprost 0.005% in Patients With Glaucoma

Glaucoma

United States
Oftalmologia Hospital Sotero del Rio

Unknown

Randomized Controlled Trial on Visual Field Training

Glaucoma

Chile
Aurolab

Unknown

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

Glaucoma

India
University of Zurich

Unknown

Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement

Glaucoma

Switzerland
Nanduri, Padma, M.D., FACS

Unknown

Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy

Glaucoma

United States
Adapt Produtos Oftalmológicos Ltda.

Unknown

Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.

Glaucoma

Brazil
Centre Hospitalier Universitaire Dijon

Completed

Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD

Glaucoma

France
University of Roma La Sapienza
vingolo enzo maria; domanico daniela; salvatore serena

Completed

Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients

Glaucoma

Italy
Samsung Medical Center

Unknown

The Effect of Bevacizumab on the Trabeculectomy (bevazicumab)

Glaucoma

Korea, Republic of
Aurolab

Completed

Study of PGA Suture in Ophthalmology

Glaucoma

India
University Health Network, Toronto

Completed

Sleep at 30 Degrees in Glaucoma

Glaucoma

Canada
Yonsei University

Unknown

Discriminating Ability of the Cirrus High Definition (HD) Optical Coherence Tomography (OCT) for Glaucoma

Glaucoma

Korea, Republic of
Pro Top & Mediking Company Limited

Terminated

OculusGen-Glaucoma Historical Control Study in Taiwan

Glaucoma

Taiwan
Allergan

Completed

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

Ocular Hypertension | Glaucoma

United States
Yonsei University

Unknown

Personality Characteristics and Compliance With Antiglaucoma Medication (GDC)

Glaucoma

Korea, Republic of
Genovate Biotechnology Co., Ltd.,
Allergan Medical

Unknown

Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy

Glaucoma

Taiwan
University of Toronto

Completed

Compliance and Administration Technique in Topical Drug Therapy of Glaucoma

Glaucoma

Canada
Nanjing Immunophage Biotech Co., Ltd
Zhejiang Hospital

Recruiting

Phase 1 Study for IPG11406 in Health Volunteer

Inflammatory Bowel Diseases

China
Leiden University Medical Center
University Medical Center Groningen; UMC Utrecht; Erasmus Medical Center; Medical... and other collaborators

Recruiting

Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy. (OVI-IBD)

Inflammatory Bowel Diseases

Netherlands
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Takeda

Recruiting

VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER) (DOPER)

Inflammatory Bowel Diseases

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Celltrion

Active, not recruiting

A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC (PEREM)

Inflammatory Bowel Diseases

France
Jiangsu vcare pharmaceutical technology co., LTD

Completed

Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects

Inflammatory Bowel Diseases

China
Hutchison Medipharma Limited

Completed

Phase I Clinical Trial in Healthy Male Volunteers

Inflammatory Bowel Diseases
Shaare Zedek Medical Center

Completed

The Role of Peripheral and Tissue Chitinase 3-like 1 Protein Levels as a Bio-marker in IBD

Inflammatory Bowel Diseases

Israel
NYU Langone Health

Withdrawn

Managing Infliximab Reinduction After Temporary Discontinuation of Drug

Inflammatory Bowel Disease
Skane University Hospital

Completed

Preparation Prior to Colonoscopy in Children

Inflammatory Bowel Diseases

Sweden
Millennium Pharmaceuticals, Inc.

Completed

Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab

Inflammatory Bowel Disease

United Kingdom

3

Subscribe